NASDAQ:MDSO - Medidata Solutions Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medidata Solutions Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $92.22 0.00 (0.00 %) (As of 10/28/2019) Add Compare Today's Range$92.21Now: $92.22▼$92.2650-Day Range$91.79MA: $92.20▼$92.2552-Week Range$60.10Now: $92.22▼$98.60Volume7.30 million shsAverage Volume1.24 million shsMarket Capitalization$5.76 billionP/E Ratio96.06Dividend YieldN/ABeta1.22 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Prepackaged software Sub-IndustryHealth Care Technology SectorMedical Current SymbolNASDAQ:MDSO Previous Symbol CUSIP58471A10 CIK1453814 Webhttp://www.mdsol.com/ Phone212-918-1800Debt Debt-to-Equity Ratio0.27 Current Ratio2.56 Quick Ratio2.56Price-To-Earnings Trailing P/E Ratio96.06 Forward P/E Ratio118.23 P/E Growth6.95 Sales & Book Value Annual Sales$635.70 million Price / Sales9.06 Cash Flow$1.69 per share Price / Cash Flow54.55 Book Value$10.32 per share Price / Book8.94Profitability EPS (Most Recent Fiscal Year)$0.96 Net Income$51.92 million Net Margins6.43% Return on Equity8.64% Return on Assets5.73%Miscellaneous Employees1,998 Outstanding Shares62,460,000Market Cap$5.76 billion Next Earnings DateN/A OptionableOptionable Receive MDSO News and Ratings via Email Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter. Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions What is Medidata Solutions' stock symbol? Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO." How were Medidata Solutions' earnings last quarter? Medidata Solutions Inc (NASDAQ:MDSO) released its quarterly earnings data on Monday, July, 22nd. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.17 by $0.31. The business had revenue of $180.50 million for the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The business's revenue for the quarter was up 15.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.43 EPS. View Medidata Solutions' Earnings History. What price target have analysts set for MDSO? 7 equities research analysts have issued twelve-month price targets for Medidata Solutions' stock. Their forecasts range from $74.93 to $96.00. On average, they anticipate Medidata Solutions' share price to reach $89.09 in the next twelve months. This suggests that the stock has a possible downside of 3.4%. View Analyst Price Targets for Medidata Solutions. What is the consensus analysts' recommendation for Medidata Solutions? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 7 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions. Has Medidata Solutions been receiving favorable news coverage? Media headlines about MDSO stock have trended very positive this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medidata Solutions earned a news impact score of 3.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Medidata Solutions. Who are some of Medidata Solutions' key competitors? Some companies that are related to Medidata Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Cortexyme (CRTX), Allscripts Healthcare Solutions (MDRX), Vocera Communications (VCRA), HealthStream (HSTM) and Computer Programs & Systems (CPSI). What other stocks do shareholders of Medidata Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), Alibaba Group (BABA), IBM (IBM), Intel (INTC), Ionis Pharmaceuticals (IONS) and Tesla (TSLA). Who are Medidata Solutions' key executives? Medidata Solutions' management team includes the folowing people: Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)Mr. Rouven Bergmann, Chief Financial Officer (Age 46)Mr. Michael Pray, Exec. VP - Gen. Mang. of Global Sales (Age 53)Ms. Jill Larsen, Exec. VP - HR & Chief HR Officer (Age 46) Who are Medidata Solutions' major shareholders? Medidata Solutions' stock is owned by a number of of retail and institutional investors. Top institutional investors include Westpac Banking Corp (0.04%). Company insiders that own Medidata Solutions stock include Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions. Which institutional investors are selling Medidata Solutions stock? MDSO stock was sold by a variety of institutional investors in the last quarter, including Westpac Banking Corp. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael Pray and Robert Taylor. View Insider Buying and Selling for Medidata Solutions. What is Medidata Solutions' stock price today? One share of MDSO stock can currently be purchased for approximately $92.22. How big of a company is Medidata Solutions? Medidata Solutions has a market capitalization of $5.76 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions. What is Medidata Solutions' official website? The official website for Medidata Solutions is http://www.mdsol.com/. How can I contact Medidata Solutions? Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected] MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 498 (Vote Outperform)Underperform Votes: 415 (Vote Underperform)Total Votes: 913MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2020 by MarketBeat.com StaffFeatured Article: Why are gap-down stocks important?